Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
We are seeking an accomplished and visionary Executive Director, Analytical Development & Quality Control (ADQC) to provide enterprise leadership for analytical development, quality control, and CMC analytical strategy across our expanding oncology portfolio.
As a member of the Pharmaceutical Development & Manufacturing (PDM) Extended Leadership Team and the ADQC Leadership Team, this executive will define the long-term analytical vision, build organizational capabilities, and establish scalable analytical and quality control strategies that enable rapid development while supporting late-stage development and commercialization.
Responsibilities:
Technical, Strategic and Organization Partnerships
Serve as a key member of the Pharmaceutical Development & Manufacturing (PDM) Extended Leadership Team, influencing enterprise CMC strategy, portfolio prioritization, and cross-functional business decisions.
Define and execute the enterprise analytical development and quality control strategy aligned with corporate objectives, portfolio priorities, and commercialization goals.
Provide scientific and strategic leadership for analytical development across the product lifecycle, including analytical characterization, specification development, impurity profiling, stability, comparability, and analytical method lifecycle management.
Establish phase-appropriate analytical control strategies that ensure product quality, process understanding, regulatory compliance, and successful technology transfer from early development through commercialization.
Partner cross-functionally to ensure analytical strategies support accelerated development while maintaining scientific rigor, regulatory compliance, and commercial readiness.
Provide executive analytical leadership for global regulatory submissions, including INDs, IMPDs, NDAs, MAAs, JNDAs, and other international filings, and represent the company during health authority interactions, inspections, and regulatory meetings.
Champion innovation through implementation of advanced analytical technologies, laboratory digitalization, automation, and data-driven approaches.
Build organizational capability by fostering scientific excellence, innovation, continuous improvement, accountability, collaboration, and inclusion across the ADQC organization.
Foster strategic scientific collaborations with external experts, industry consortia, and technology partners while leveraging emerging analytical technologies and best practices.
External Partnerships
Define and execute the enterprise strategy for a high-performing global network of CDMOs, CROs, and contract testing laboratories.
Build strategic partnerships that enhance technical capabilities, operational scalability, business continuity, and commercialization readiness.
Provide executive oversight of outsourced analytical development, analytical method validation, technology transfer, and lifecycle management across the external network.
Establish governance models, performance metrics, and executive business review processes to ensure operational excellence, quality, regulatory compliance, and continuous improvement.
Develop long-term strategic partnerships that expand analytical capabilities, improve organizational agility, and support commercialization needs.
Collaborate with external partners to drive innovation and accelerate product development while maintaining scientific excellence and compliance.
Required Skills, Experience and Education:
PhD (preferred) or MSc in Analytical Chemistry, Pharmaceutical Sciences, or related field.
~18+ years of industry experience with significant leadership in analytical development and QC.
Proven track record supporting late-stage development and global regulatory filings (IND/NDA/MAA/JNDA).
Demonstrated success leading and scaling teams (10+ years in leadership roles preferred).
Deep expertise in GMP, quality systems, and global regulatory expectations (FDA, EMA, ICH).
Extensive experience managing external analytical networks (CDMOs, CTLs).
Strong strategic thinking with the ability to make data-driven, risk-balanced decisions.
Excellent communication and stakeholder influence at executive levels.
Preferred Skills:
Experience in oncology or targeted therapies.
Background in accelerated or expedited development pathways.
Experience building analytical/QC functions in a high-growth biotech environment.
Ability to balance speed, quality, and risk in a dynamic setting.
#LI-Hybrid #LI-GL1
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy For additional information, please contact privacy@revmed.com
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
We are Revolutionaries – passionate in our singular pursuit of discovering, developing and delivering innovative, targeted medicines for patients living with cancer. To deliver on our vision, we work relentlessly in pursuit of cutting-edge therapeutic approaches to some of the toughest cancers. Our current focus is on RAS-addicted cancers, which account for 30 percent of all new human cancer diagnoses.
